Teva Of Israel Licenses Lilly Gemzar Generic To APP Pharmaceuticals
This article was originally published in PharmAsia News
Executive Summary
Israel's Teva Pharmaceutical Industries contracted with APP Pharmaceuticals to make a generic version of Eli Lilly's Gemzar (gemcitabine) chemotherapy drug